Laurion Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Laurion Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96M	Buy	+3,980	New	+$2.16M	0.09%	217
2025 Q3	–	Sell	-1,175	Closed	-$476K	–	438
2025 Q2	$476K	Buy	+1,175	New	+$491K	0.01%	256
2024 Q3	–	Sell	-50,406	Closed	-$27.9M	–	581
2024 Q2	$27.9M	Sell	50,406 -55,330	-52%	-$31.7M	0.33%	57
2024 Q1	$61.5M	Buy	105,736 +53,498	+102%	+$30M	0.52%	44
2023 Q4	$27.7M	Buy	+52,238	New	+$25.3M	0.23%	90
2023 Q3	–	Sell	-10,169	Closed	-$5.31M	–	676
2023 Q2	$5.31M	Buy	+10,169	New	+$5.49M	0.03%	259
2022 Q4	–	Sell	-5,570	Closed	-$2.95M	–	549
2022 Q3	$2.83M	Buy	5,570 +3,603	+183%	+$2.02M	0.02%	299
2022 Q2	$1.07M	Sell	1,967 -33	-2%	-$18.2K	0.02%	275
2022 Q1	$1.18M	Buy	+2,000	New	+$1.15M	0.01%	241
2021 Q4	–	Sell	-2,587	Closed	-$1.48M	–	740
2021 Q3	$1.48M	Buy	2,587 +1,303	+101%	+$715K	0.01%	471
2021 Q2	$648K	Buy	+1,284	New	+$606K	﹤0.01%	482
2021 Q1	–	Sell	-582	Closed	-$271K	–	893
2020 Q4	$271K	Sell	582 -1,800	-76%	-$844K	﹤0.01%	558
2020 Q3	$1.05M	Buy	+2,382	New	+$984K	0.01%	415
2019 Q3	–	Sell	-2,600	Closed	-$745K	–	1285
2019 Q2	$764K	Buy	+2,600	New	+$716K	0.01%	614
2019 Q1	–	Sell	-32,725	Closed	-$7.32M	–	1283
2018 Q4	$7.32M	Buy	32,725 +28,599	+693%	+$6.71M	0.13%	214
2018 Q3	$1.01M	Buy	+4,126	New	+$949K	0.01%	690
2018 Q2	–	Sell	-2,663	Closed	-$550K	–	1586
2018 Q1	$550K	Buy	+2,663	New	+$559K	﹤0.01%	997
2016 Q4	–	Sell	-9,135	Closed	-$1.35M	–	1280
2016 Q3	$1.45M	Buy	9,135 +6,962	+320%	+$1.07M	0.01%	525
2016 Q2	$321K	Sell	2,173 -4,927	-69%	-$727K	0.01%	642
2016 Q1	$1M	Buy	+7,100	New	+$952K	0.02%	425
2015 Q3	–	Sell	-2,009	Closed	-$261K	–	902
2015 Q2	$261K	Buy	+2,009	New	+$262K	﹤0.01%	540

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Laurion Capital Management's TMO Position: Q1 2026 in Review

Laurion Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 3,980 shares worth $1.96M. The stake represents 0.09% of the portfolio and ranks #217 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in TMO as recently as Q2 2025.

Laurion Capital Management first reported a position in TMO in Q2 2015 and has held it in 21 quarters since. The position peaked at $61.5M in Q1 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Laurion Capital Management held 3,980 shares of Thermo Fisher Scientific worth $1.96M as of Q1 2026.
Thermo Fisher Scientific was a new Laurion Capital Management position in Q1 2026.
Thermo Fisher Scientific made up 0.09% of Laurion Capital Management's portfolio in Q1 2026, its #217 holding.
Laurion Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 21 quarters since.
Laurion Capital Management's Thermo Fisher Scientific position peaked at $61.5M in Q1 2024.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.